Benjamin Graham Detailed Fundamental Analysis

Validea's guru fundamental report indicates Regeneron Pharmaceuticals Inc (REGN), a large-cap biotechnology stock, received a 71% rating from its Benjamin Graham Value Investor model. While REGN passed several fundamental criteria including sales and long-term EPS growth, its high P/E and Price/Book ratios caused it to fail the model's strict valuation tests, placing it below the 80% threshold typically indicating investment interest.

Analysis

Regeneron Pharmaceuticals (REGN) presents a conflicting profile according to Validea's Benjamin Graham-based value investing model, scoring 71%, which is below the 80% threshold typically indicating guru interest. The analysis reveals a fundamentally sound company, as REGN passes key operational and solvency tests, including criteria for sales, current ratio, long-term EPS growth, and maintaining low long-term debt relative to net current assets. However, despite these strong underlying fundamentals characteristic of a large-cap growth stock, REGN fails the model's stringent valuation hurdles. Specifically, its Price-to-Earnings (P/E) and Price-to-Book (P/B) ratios are too high to satisfy the deep value criteria established by Graham, leading to a mixed overall assessment.

Key Decisions for Investors

• Strict value investors should exercise caution, as the stock's failure on P/E and P/B metrics and its sub-80% score suggest it does not currently offer the margin of safety central to the Graham methodology.
• Growth-oriented investors might interpret the positive signals on long-term EPS growth and strong balance sheet fundamentals as justification for the premium valuation, warranting further analysis against biotech sector growth peers rather than deep value screens.
• Given the dichotomy between strong fundamentals and high valuation, investors should monitor for any significant price pullbacks that could bring the P/E and P/B ratios to levels more aligned with the company's operational strengths, potentially creating a more attractive entry point.